Kura Oncology annual operating margin
2024
2025
Kura Oncology Operating Margin Growth & History (KURA)
Kura Oncology's operating margin was −449.94% for fiscal 2025.
View full Kura Oncology company overviewKura Oncology annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −449.94% | −91.40 pp |
| 2024 | 2024-12-31 | −358.55% | — |
Kura Oncology quarterly operating margin
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −349.77% | +125.55 pp |
| Q1 2026 | 2026-03-31 | −431.51% | +27.10 pp |
| Q4 2025 | 2025-12-31 | −497.62% | — |
| Q3 2025 | 2025-09-30 | −385.53% | — |
| Q2 2025 | 2025-06-30 | −475.31% | — |
| Q1 2025 | 2025-03-31 | −458.61% | — |
Kura Oncology operating margin trends
Across the available reported history, Kura Oncology's operating margin decreased from −358.55% to −449.94%, a change of −91.40 percentage points. The latest reported quarter, Q2 2026, shows −349.77%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kura Oncology filings at SEC.gov ↗